| scholarly article | Q13442814 |
| P356 | DOI | 10.2146/AJHP090526 |
| P953 | full work available at URL | http://academic.oup.com/ajhp/article-pdf/67/19/1599/28345239/ajhp1599.pdf |
| http://www.ajhp.org/cgi/content/abstract/67/19/1599 | ||
| P698 | PubMed publication ID | 20852160 |
| P2093 | author name string | Ann O. Karosas | |
| P2860 | cites work | Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma | Q46827781 |
| A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. | Q51768835 | ||
| Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma? | Q53574253 | ||
| Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors. | Q53650236 | ||
| Treatment of clinically localized Ewing's sarcoma with radiotherapy and combination chemotherapy | Q53803088 | ||
| Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study | Q64211472 | ||
| Proceedings: Disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy | Q69736404 | ||
| Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study | Q70179822 | ||
| Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma | Q70505771 | ||
| Ewing's sarcoma and the "peanut" tumors | Q72039751 | ||
| Musculoskeletal tumors of childhood | Q73300881 | ||
| Cyclophosphamide in children with cancer | Q79053842 | ||
| Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group | Q80142702 | ||
| Therapy for metastatic ESFT: is it time to ask new questions? | Q80252016 | ||
| Lower back pain and mass in a 13-year-old girl | Q81301196 | ||
| Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience | Q82847771 | ||
| Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma) | Q94801370 | ||
| Diagnosis and treatment of Ewing's sarcoma | Q28286292 | ||
| Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults | Q33446946 | ||
| Role of tyrosine kinase inhibitors in cancer therapy | Q34432091 | ||
| Survival after recurrence of Ewing's sarcoma family of tumors | Q36076700 | ||
| Ewing's sarcoma and primitive neuroectodermal family of tumors. | Q36153561 | ||
| Ten-Year Follow-Up of a Patient with Metastatic Ewing's Sarcoma of the Pelvis | Q36674175 | ||
| Therapeutic potential of directed tyrosine kinase inhibitor therapy in sarcomas | Q37038356 | ||
| Pediatric sarcomas occurring in adults. | Q37089124 | ||
| Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival | Q40158315 | ||
| Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. | Q40427655 | ||
| Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant. | Q40471939 | ||
| Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors. | Q42162649 | ||
| High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma. | Q42545990 | ||
| Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. | Q43543641 | ||
| High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. | Q43626751 | ||
| Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone | Q44320806 | ||
| High-dose chemotherapy and autologous peripheral blood stem cell transfusion for adult and adolescent patients with small round cell sarcomas | Q44808020 | ||
| Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study | Q44961871 | ||
| Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study | Q44978596 | ||
| Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial | Q45230926 | ||
| Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A Pediatric Oncology Group Phase II study | Q46382300 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1599-1605 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | American Journal of Health-System Pharmacy | Q15754037 |
| P1476 | title | Ewing's sarcoma | |
| Ewing’s sarcoma | |||
| P478 | volume | 67 |
| Q37390973 | APLP2 regulates the expression of MHC class I molecules on irradiated Ewing's sarcoma cells |
| Q55069980 | Adrenal Ewing's Sarcoma in an Elderly Man. |
| Q89207211 | Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO) |
| Q33275227 | Brain metastasis in bone and soft tissue cancers: a review of incidence, interventions, and outcomes |
| Q41963515 | Clinicopathologic characteristics and outcome of childhood and adolescent Ewing's sarcoma in center of Iran. |
| Q34276911 | Do long term survivors of ewing family of tumors experience low bone mineral density and increased fracture risk? |
| Q45335533 | Ewing's sarcoma of the patella. |
| Q34166817 | Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma |
| Q30575805 | Reanalysis of RNA-sequencing data reveals several additional fusion genes with multiple isoforms |
| Q33801548 | Systemic Therapy Outcomes in Adult Patients with Ewing Sarcoma Family of Tumors |
| Q28397404 | Targeting PI3K/Akt represses Hypoxia inducible factor-1α activation and sensitizes Rhabdomyosarcoma and Ewing's sarcoma cells for apoptosis |
| Q42426271 | Metastasis from scapular Ewing′s sarcoma presenting as sutural diastasis: An unusual presentation | main subject | P921 |
Search more.